semaglutide vs tirzepatide for inflammation GLP-1 is more than weight loss. 🧬 Semaglutide, Tirzepatide, and Retatrutide are not “diet peptides.” They are metabolic signaling tools that influence insulin sensitivity, inflammation, appetite regulation, and overall metabolic health. Understanding semaglutide vs tirzepatide mechanism What's

Liver-directed therapies with efficacy in metabolic dysfunction-associated steatotic liver disease (MASLD), including incretin-based agents, fibroblast growth factor 21 analogs, peroxisome proliferator-activated receptor agonists, and thyroid hormone receptor beta agonists, may benefit selected MetALD patients

When a breakthroughmedicationpromises hope and renewed health, only to be blocked by an insurance denial, the blow is deeply personal

Innovation, affordability, or competition

turns out several are still offering compounded GLP-1s

Made in the USA in an FDA-registered, GMP-certified facility and 3rd-party tested for quality

June 6, 2025 A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events and inpatient admissions